Skip to main content

Table 1 Clinical characteristics of cirrhotic patients with and without HCC.

From: A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease

 

Cirrhosis

HCC

Number

49

45

Age (years)

56.73 ± 8.9

67.8 ± 7.4

Male:Female

35:14

37:8

ALD:NAFLD

28:21

28:17

Childs-Pugh A:B:C

30:14:05

24:16:05

AFP (ng/ml)

6.04 ± 2.68

6551 ± 13602

Bilirubin (μmol/L)

33.42 ± 30.81

22.87 ± 22.29

Albumin (g/l)

36.36 ± 7.76

35.71 ± 5.02

Portal vein invasion

NA

8

Single nodule

NA

19

Two nodules

NA

8

≥ 3 nodules

NA

18

  1. The difference in age between patients with cirrhosis and HCC versus those with cirrhosis alone was statistically significant (p < 0.001). There was no significant difference between sex or Child-Pugh stage between the two groups.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us